FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a method for reducing the blood uric acid concentration involving administering a compound of formula I or a pharmaceutically acceptable salts thereof. 
Besides, the present invention refers to a method of treating preventing a number of conditions, including uratic arthritis, hyperuricemia, the uric acid levels exceeding those normally diagnosed as hyperuricemia.
EFFECT: declared compound of formula I may be used in the pharmaceutical composition.
22 cl, 6 dwg, 13 tbl, 28 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501555C2 |
| TETRAZOLE COMPOUNDS FOR REDUCING CONCENTRATION OF URIC ACID | 2009 |
|
RU2522458C2 |
| COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | 2006 |
|
RU2420276C2 |
| COMPOUND FOR TREATING METABOLIC DISORDERS | 2008 |
|
RU2521284C2 |
| COMPOUNDS FOR TREATING METABOLIC DISEASES | 2008 |
|
RU2502723C2 |
| COMPOUNDS FOR TREATMENT OF METABOLIC DISEASES | 2002 |
|
RU2341513C2 |
| COMPOUNDS FOR METABOLIC DISORDER TREATMENT | 2004 |
|
RU2358722C2 |
| TYPE 1 DIACYLGLYCEROL O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2497816C2 |
| AMIDO-SUBSTITUTED DERIVATIVES OF XANTHINE POSSESSING INHIBITORY EFFECT ON ACTIVITY OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (PEPCK), METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND USING | 2003 |
|
RU2295525C2 |
| 4H-PYRAN DERIVATIVES, MIXTURE OF ISOMERS THEREOF, INDIVIDUAL ISOMERS AND SALTS THEREOF | 1996 |
|
RU2164915C2 |
